Latest Cancer treatments Stories
immunoSEQ(TM) Next Generation Sequencing Assay Confirms Presence of Active Immune Response in Responders Prior to Treatment SEATTLE, Nov.
-- Plans to Initiate Clinical Studies of Proprietary CAR-T Cell Immunotherapy for Selected Solid Tumors -- SHANGHAI, Nov.
Another Active Immunotherapy Product Added to Inovio's Growing Cancer R&D Pipeline PLYMOUTH MEETING, Pa., Nov. 20, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
A few treatment options and tips for one dealing with lung cancer. (PRWEB) November 12, 2014 For such a serious medical condition, the symptoms warning
Exploratory Study is First to Evaluate Novel microRNA Replacement Therapy for the Treatment of Malignant Pleural Mesothelioma SYDNEY, Nov.
BETHESDA, Md., Nov. 7, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S.
Results presented in poster presentation beginning today and in oral presentation Saturday, November 8, at 1:40 PM at Society for Immunotherapy of Cancer annual meeting. ANN ARBOR,
Trial will be one of the first of its kind; based on previous success with immunotherapy for patients with recurring leukemia SEATTLE, Nov.
More Images (3 images) »